Pseudogout vs. Gout: What’s the Difference?

Pseudogout vs. Gout: What’s the Difference?

By Kelly Burch
Updated on August 15, 2023
Medically reviewed by Stella Bard, MD

Table of Contents
View All
Table of Contents

Experiencing a sudden, intensely painful, red, and swollen joint can be alarming, pointing towards either gout or pseudogout. Both are forms of arthritis—an autoimmune condition that leads to joint inflammation—arising from microscopic crystal buildup within the joint space. Specifically, gout results from uric acid crystal deposition, while pseudogout, referring to acute attacks of calcium pyrophosphate deposition disease (CPPD), involves calcium pyrophosphate crystals. The striking similarity in their clinical presentation makes differentiation challenging without specialized testing, a fact reflected in pseudogout's name, meaning "false gout."

Despite their similar appearance, accurately distinguishing between true gout and pseudogout is paramount for effective treatment and long-term management. The precise crystal type involved fundamentally dictates the therapeutic pathway, influencing both immediate relief and strategies for preventing future episodes. Therefore, a thorough medical evaluation is indispensable when these acute joint symptoms arise, guiding patients toward the most appropriate and effective care plan tailored to their specific condition.

Jan-Otto / Getty Images

Symptoms

While gout and pseudogout present with remarkable similarities, subtle distinctions in their symptom profiles can offer preliminary clues. Both conditions typically manifest with a sudden, often excruciating onset of pain in an affected joint. This intense discomfort is invariably accompanied by pronounced signs of inflammation, including marked redness, a sensation of warmth to the touch, and significant swelling. These acute episodes develop rapidly, demanding prompt medical attention to alleviate suffering and prevent potential complications.

Pseudogout

Pseudogout frequently targets specific joints at symptom onset, commonly favoring larger articulations such as the knees, ankles, and wrists. As the condition progresses, or in subsequent episodes, crystalline deposits can affect a broader range of joints, including the hips, shoulders, elbows, fingers, and toes; it rarely manifests in the neck. A key distinguishing feature is the typical duration of its inflammatory episodes. While sudden, symptoms tend to persist for considerably longer than gout, often lasting weeks, and in some cases, up to three months. This prolonged nature can significantly impact quality of life and presents a challenge in symptom relief.

Gout

Gout typically makes its dramatic debut in a single joint, especially during initial stages. The joint most famously and often initially affected is the big toe. This condition, colloquially known as "podagra," can also first manifest in the foot, ankle, or knee. The intensity of a gout attack is remarkable, with pain often escalating to its maximum severity within 24 hours of onset. Despite this profound and sudden onset, a notable characteristic distinguishing gout from pseudogout is its comparatively shorter duration. Symptoms typically begin to subside within one to two weeks, gradually lessening until the joint returns to its normal state.

Causes

Both pseudogout and gout are crystal-induced arthropathies, meaning they are caused by the formation and deposition of specific crystals within joints, which incite painful inflammation. Despite this shared mechanism, the fundamental difference lies in the chemical composition of these crystals and the distinct metabolic pathways or factors that lead to their accumulation. Understanding these underlying causes is crucial for effective prevention and targeted treatment strategies.

Pseudogout

Pseudogout is primarily driven by calcium pyrophosphate crystal accumulation within articular cartilage and synovial fluid. While the precise cause remains under investigation, their presence becomes significantly more common with advancing age; indeed, these crystal deposits are often observed in elderly individuals, though not always leading to symptomatic attacks. Healthcare providers identify several contributing factors, including metabolic imbalances like hyperparathyroidism, altered levels of magnesium and iron, and genetic predisposition. Importantly, merely having these crystals, as seen in many older adults, does not automatically lead to pseudogout symptoms.4

Gout

Gout, in contrast, results from uric acid crystal buildup due to either excessive production or, more commonly, inefficient kidney excretion. Elevated uric acid levels (hyperuricemia) are influenced by genetics and compromised kidney function. For predisposed individuals, diet plays a significant role; high-purine foods like red meats, high-fructose corn syrup, alcohol (especially beer), and soft drinks can elevate uric acid. Uric acid is a purine breakdown byproduct, normally expelled via urine and feces. When the body cannot excrete excess, it crystallizes into sharp, needle-like structures in joints. Physical stress, such as from surgery, and dehydration can also concentrate uric acid, triggering flares.5

Diagnosis

Accurately differentiating between gout and pseudogout is critical for effective treatment. If you suspect these conditions, promptly consult a healthcare provider. Diagnosis begins with a comprehensive clinical evaluation, including symptom history and family history, as both conditions can have a genetic component. The most definitive procedure is arthrocentesis: aspirating fluid from the affected joint. Microscopic analysis of this synovial fluid sample identifies the specific crystal type—needle-shaped uric acid crystals confirm gout, while rhomboid-shaped calcium pyrophosphate crystals confirm pseudogout.

Imaging

Various imaging technologies support diagnosis. Ultrasound can help visualize crystal deposits and assess inflammation within and around the joints. X-rays can reveal signs of chronic crystal deposition, such as joint damage or chondrocalcinosis (calcification in cartilage), characteristic of pseudogout. Computed Tomography (CT) scans offer more detailed cross-sectional images, aiding in the assessment of crystal burden and associated joint destruction. While imaging provides valuable evidence and helps rule out other conditions, it typically complements, rather than replaces, the crucial joint fluid analysis for definitive crystal identification.

Treatment

Prompt, appropriate treatment is paramount for restoring quality of life from the intense pain and limited mobility of pseudogout and gout. Acute flare management for both conditions aims to rapidly alleviate pain and reduce inflammation. Healthcare providers typically recommend nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or Indocin, and corticosteroids such as Medrol or prednisone. Colchicine can also reduce joint swelling and prevent further attacks, particularly when taken within 24 hours of symptom onset.6

Beyond oral medications, arthrocentesis—removing fluid from the joint with a needle—offers immediate pressure relief and confirms diagnosis. Following fluid removal, corticosteroids may be directly injected into the joint space for potent, localized anti-inflammatory effects. Prompt treatment is crucial for acute gout attacks; early intervention significantly shortens their duration and intensity. While these interventions manage immediate episodes, long-term strategies for preventing future occurrences differ significantly based on the underlying condition.7

Pseudogout

For pseudogout, no specific treatment currently dissolves or eliminates calcium pyrophosphate crystals once formed. Thus, management focuses on controlling symptoms and preventing acute inflammatory attacks. This involves ongoing anti-inflammatory medications or pain relievers to manage chronic discomfort and reduce flare frequency. Regular monitoring is essential to adjust regimens. In severe cases where extensive crystal buildup has led to significant joint damage, particularly degenerative arthritis or osteoarthritis, joint replacement surgery may be considered to alleviate intractable pain and improve joint function.

Gout

Gout management extends beyond acute attacks to fundamentally lower blood uric acid levels, preventing future episodes and mitigating long-term joint damage. A significant component involves specific lifestyle modifications to decrease uric acid production and enhance its excretion. Key adjustments include strictly avoiding alcohol and sweetened beverages while increasing daily water intake, which aids uric acid excretion. Reducing stress, and adhering to a low-purine diet (e.g., less red meat, sweets) are also beneficial. Regular exercise and achieving a healthy weight are crucial.

In conjunction with these lifestyle changes, healthcare providers prescribe uric acid-reducing drugs. These medications either decrease the body's uric acid production (e.g., allopurinol, febuxostat) or enhance kidney excretion (e.g., probenecid). This effectively controls blood uric acid levels, preventing new crystal formation and accumulation, thereby minimizing recurrence of gout flares and preserving joint health. This proactive approach enables individuals to live a life free from the debilitating pain associated with this condition.7

A Word From Verywell

Experiencing sudden, severe joint pain and limited mobility can be unsettling. It underscores the critical importance of joint health. Regardless of whether your symptoms point towards gout or pseudogout, promptly consulting a qualified healthcare provider is paramount. A professional diagnosis is indispensable, as it confirms the specific condition and lays the foundation for managing symptoms and improving your long-term health and quality of life.

Understanding the precise distinction between these two crystal-induced arthropathies is key to tailored management. For pseudogout, treatment primarily controls symptoms like pain and inflammation. Conversely, for true gout, the therapeutic approach extends beyond acute symptom management to proactive measures, including targeted lifestyle adjustments and specific prescription medications, aimed at lowering blood uric acid levels. These interventions significantly reduce the risk of future painful episodes, enabling you to live a life free from chronic joint pain.

7 Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.

  1. Arthritis Foundation. Gout or pseudogout?
  2. MacMullan, Paul. Treatment and management of pseudogout: insights for the clinician. Therapeutic Advances in Musculoskeletal Disease. doi:10.11772F1759720X11432559
  3. National Institute of Arthritis and Mucsuloskeletal and Skin Diseases. Gout.
  4. Arthritis Foundation. Calcium pyrophosphate deposition.
  5. Montana Department of Public Health and Human Services. Gout.
  6. Arthritis Foundation. Gout or pseudogout?
  7. Arthritis Foundation. Gout.

By Kelly Burch Burch is a New Hampshire-based health writer with a bachelor's degree in communications from Boston University.
See Our Editorial Process
Meet Our Medical Expert Board